Clinical Trial Update: Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates Mitazalimab is being tested in combination with standard chemotherapy for immunotherapy-resistant advanced biliary tract cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Mitazalimab (mitazalimab)

Snippet

Sponsor: UNICANCER | Conditions: Biliary Tract Cancer (BTC) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING